BSV Iii-xf Asi
Startup rounds since 2014 with a BSV Iii-xf Asi investor on the board, and the firm's own fund filings.
Raises
11
since 2014
Unannounced
1
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Delphinus Medical Technologies, Inc.$27.6M
- Ablative Solutions, Inc.$29.3M
- Delphinus Medical Technologies, Inc.$5M
- Delphinus Medical Technologies, Inc.$30.4M
- Ablative Solutions, Inc.$54.5M
- Neochord Inc$4.03M
- Delphinus Medical Technologies, Inc.$8.23M
- Delphinus Medical Technologies, Inc.$39.5M
- Neochord Inc$12.6M
- Neochord Inc$457K
- Great Lakes Pharmaceuticals, Inc.$11.2M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2025 | 1 | 1 |
| 2024 | 1 | — |
| 2023 | 1 | — |
| 2022 | 1 | — |
| 2021 | 1 | — |
| 2017 | 2 | — |
| 2015 | 3 | — |
| 2014 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Bsv Iii-xf Asi Spv, LLC | 15 Mar 2019 | $993K | — |
Listed because a BSV Iii-xf Asi fund's filing names a director of each company. A name match is not a verified identity.